Why are mineralocorticoid receptors so nonselective?

Current Hypertension Reports

Volumn 9, Issue 2, 2007, Pages 112-116

  Funder, John W ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ALDOSTERONE; CARBENOXOLONE; CHORIONIC GONADOTROPIN; DEXAMETHASONE; EPLERENONE; FLUTAMIDE; HYDROCORTISONE; MINERALOCORTICOID RECEPTOR; POTASSIUM; PROGESTERONE; SPIRONOLACTONE;

ALDOSTERONE BLOOD LEVEL; ANTIHYPERTENSIVE ACTIVITY; BINDING AFFINITY; BLOOD PRESSURE MEASUREMENT; DIASTOLIC BLOOD PRESSURE; DRUG DOSE TITRATION; DRUG EFFICACY; HOMEOSTASIS AND REGULATION; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HUMAN; HYPERTENSION; IC 50; NONHUMAN; PATHOPHYSIOLOGY; POTASSIUM BLOOD LEVEL; PROGESTERONE SYNTHESIS; RECEPTOR AFFINITY; REVIEW; SYNCYTIOTROPHOBLAST; SYSTOLIC BLOOD PRESSURE;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ALDOSTERONE; BLOOD PRESSURE; HUMANS; HYDROCORTISONE; HYPERTENSION; PROGESTERONE; RECEPTORS, MINERALOCORTICOID;

EID: 34248996560     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-007-0020-8     Document Type: Review

References (28)

1. Krozowski ZS, Funder JW: Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity. Proc Natl Acad Sci U S A 1983, 80:6056-6060.
2. Arriza JL, Weinberger C, Cerelli G, et al.: Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 1987, 237:268-275.
3. Myles K, Funder JW: Progesterone binding to mineralocorticoid receptors: in vitro and in vivo studies. Am J Physiol 1996, 270:E601-E607.
4. Crabbe J: Stimulation of active sodium transport by the isolated toad bladder with aldosterone in vitro. J Clin Invest 1961, 40:2103-2110.
5. Rousseau G, Baxter J, Funder J, et al.: Glucocorticoid and mineralocorticoid receptors for aldosterone. J Steroid Biochem 1972, 3:219-227.
6. Funder JW, Pearce P, Smith R, Smith AI: Mineralocorticoid action: target-tissue specificity is enzyme, not receptor, mediated. Science 1988, 242:583-585.
7. Edwards CR, Stewart PM, Burt D, et al.: Localisation of 11 beta-hydroxysteroid dehydrogenase - tissue specific protector of the mineralocorticoid receptor. Lancet 1988, 2:986-989.
8. Funder JW, Myles K: Exclusion of corticosterone from epithelial mineralocorticoid receptors is insufficient for selectivity of aldosterone action: in vivo binding studies. Endocrinology 1996, 137:5264-5268.
9. Young M, Moussa L, Dilley R, Funder JW: Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11 beta-hydroxysteroid dehydrogenase inactivation. Endocrinology 2003, 144:1121-1125.
10. Funder JW: Is aldosterone bad for the heart? Trends Endocrinol Metab 2004, 15:139-142.
11. Funder JW: RALES, EPHESUS and redox. J Steroid Biochem Mol Biol 2005, 93:121-125.
12. Funder JW: How do central mineralocorticoid receptors modulate blood pressure? Am J Physiol 2005, 288: R356-R357.
13. Funder JW, Pearce PT, Smith R, Campbell J: Vascular type I aldosterone binding sites are physiological mineralocorticoid receptors. Endocrinology 1989, 125:2224-2226.
14. Romagni P, Rossi F, Guerrini L, et al.: Aldosterone induces contraction of the resistance arteries in man. Atherosclerosis 2003, 166:345-349.
15. Alzamora R, Michea L, Marusic ET: Role of 11beta-hydroxysteroid dehydrogenase on nongenomic aldosterone effects in human arteries. Hypertension 2000, 35:1099-1104.
16. Levy D, Rocha R, Funder JW: Distinguishing the antihypertensive and electrolyte effects of eplerenone. J Clin Endocrinol Metab 2004, 89:2736-2740.
17. Brilla CG, Weber KT: Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. J Lab Clin Med 1992, 120:893-901.
18. Young M, Fullerton M, Dilley R, Funder J: Mineralocorticoids, hypertension, and cardiac fibrosis. J Clin Invest 1994, 93:2578-2583.
19. Rocha R, Martin-Berger C, Yang P, Scherrar R: Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart. Endocrinology 2002, 143:4828-4836.
20. Nagara K, Obata K, Xu J, et al.: Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-renin, low-aldosterone hypertensive rats. Hypertension 2006, 47:656-664.
21. Makhanova N, Sequeira-Lopez MLS, Gomez RA: Disturbed homeostasis in sodium restricted mice heterozygous and homozygous for aldosterone synthase gene disruption. Hypertension 2006, 48:1151-1159.
22. Hu X, Funder JW: The evolution of mineralocorticoid receptors. Molecular Endocrinology 2006, 20:1471-1478.
23. Mitro N, Mak PA, Vargas L, et al.: The nuclear receptor LXR is a glucose sensor. Nature 2007, 445:219-223.
24. Reinking J, Lam MM, Pardee K, et al.: The Drosophila nuclear receptor e75 contains heme and is gas responsive. Cell 2005, 122:197-207.
25. Patel F, Sun Y, Challis J: Local modulation by 11beta-hydroxysteroid dehydrogenase of glucocorticoid effects on the activity of 15-hydroxyprostaglandin dehydrogenase in human chorion and placental trophoblast cells. J Clin Endocrinol Metab 1999, 84:395-400.
26. Funder JW: 15-Hydroxyprostaglandin dehydrogenase: Cinderella meets Prince Serendip. J Clin Endocrinol Metab 1999, 84:393-394.
27. Patel FA, Challis JR: Cortisol/progesterone antagonism in regulation of 15-hydroxysteroid dehydrogenase activity and mRNA levels in human chorion and placental trophoblast cells at term. J Clin Endocrinol Metab 2002, 87:700-708.
28. Fru KN, VandeVoort CA, Chaffin CL: Mineralocorticoid synthesis during the periovulatory interval in macaques. Biol Reprod 2006, 75:568-574.